VERTEX PHARMACEUTICALS INC / MA (VRTX)
@VRTX.asset
$501.15
At close:
Vertex Pharmaceuticals Inc is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases in specialty markets.
Figures
- Sector Healthcare
- Industry Biotechnology
- Index Nasdaq-100, S&P 500
- Market Cap $128.69 B
- Last Earnings Report Feb 13, 2025
- Price Reaction to Earnings Report -3.95%
- Enterprise Value $122.69 B
- P/E ratio -241.31
- Price/Sales ratio 11.73
- EV/Sales ratio 11.13
- Price/Book Value 7.88
- Revenue $11.02 B
- EBIT $4.31 B
- Net Income $-0.54 B
- Gross Profit $9.49 B
- Free Cash Flow $-0.98 B
- EBIT Margin 39.10%
- Gross Margin 86.11%
- FCF Margin -8.87%
- Return on Equity -3.26%
- Equity Ratio 72.82%
- Debt/Equity Ratio 0.37
- 6-month Performance 6.37%
- 12-month Performance 25.24%
- Trend reversal neutral
What the community is saying
| Nobody said anything, yet! Speak your mind and be the first to create a new topic. |